Dendreon Announces Presentation of Data at the American Association of Cancer Research Annu... ( SEATTLE April 6 2011 /- Dendreon Corp...)

Dendreon Announces Presentation of Data at the American Association of Cancer Research Annual Meeting

Date:4/6/2011

SEATTLE, April 6, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the following data presentations taking place at the American Association of Cancer Research (AACR) 102nd Annual Meeting 2011 in Orlando, Florida:

Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m. ET. "B lymphocytes are activated during the course of sipuleucel-T treatment, leading to an antigen-specific humoral response." Poster presentation.
Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m. ET. "Evidence of T lymphocyte activation following sipuleucel-T treatment." Poster presentation.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon's first autologous cellular immunotherapy product, PROVENGE® (sipuleucel-T), was approved by the FDA in April 2010. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer. The Company is headquartered in Seattle, Washington and has manufacturing facilities in New Jersey, Georgia and California. Dendreon is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/.

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/21/2013)... Mass. , May 21, 2013 /PRNewswire/ ... research and advisory firms for pharmaceutical and ... an emerging agent on key efficacy endpoints, ... progression, has the most influence over surveyed ... advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast cancer. ...

(Date:5/21/2013)... , May 21, 2013 Hurel Corporation ("Hurel"), ... microfluidic cell-based assay platforms, today announced the appointment of ... to the Company,s Board of Directors. Dr. MacDonald is ... the Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical ... by Merck & Co. in 2009. Over ...

(Date:5/21/2013)... 2013 Reportlinker.com announces that a ... its catalogue: ... Coherence Tomography (OCT) http://www.reportlinker.com/p01187977/Global-Markets-and-Technologies-for-Optical-Coherence-Tomography-OCT.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ... BCC,s aim ... synopsis of the current and future characteristics ...

[0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors [0] Global Markets and Technologies for Optical Coherence Tomography (OCT)

... treating the diabetes patient, doctors discussed how a ... not enough to reveal an individual,s risk for ... Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical ... "We need to be more aggressive in treating ...

... Corporation (Nasdaq: BPUR ) announced ... U.S. Naval Medical Research Center (NMRC) by letter that it ... Hemopure(R) [hemoglobin glutamer -- 250 (bovine)] under a proposed protocol ... announced, the study, "Restore Effective Survival in Shock" (RESUS) was ...

Cached Medicine Technology:Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient 2 U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold 2 U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold 3

Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold

(Date:5/21/2013)... Diehard soccer fans will definitely want to see a ... between Manchester City and Chelsea FC at Busch ... teams are highly decorated in the English Premiere League of ... Busch Stadium, home of the St. Louis Cardinals, a professional ... a professional sporting event and non-baseball game will be held ...

(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay ... life, but some of the changes brought about by ... diabetes. New research has found that people with ... percent higher risk of having a severe low blood ... compared to people with diabetes who aren,t depressed. ...

(Date:5/21/2013)... Philosophical Society (APS) has awarded New York University neuroscientist ... in recognition of his "pioneering work on the neuroscience ... University,s Center for Neural Science, is the second NYU ... yearsJoseph LeDoux received the honor in 2011 in recognition ... emotional learning, particularly fear learning, and fear memory." ...

(Date:5/21/2013)... Representatives with Hammerhead Bicycles announced today that their re-launched bike ... achieved its overall goal of becoming a standalone brand. , ... Bicycles from a house brand to a standalone bike brand,” ... that the bike shop will go forward as Switchback ... 29er and 650b. , “The bike shop will ...

(Date:5/21/2013)... major Ohio universities and four hospitals have joined with ... collaborative research program aimed exclusively at finding the unknown ... to invest $10 million in the program over five ... Center -- Ohio Collaborative is a unique research enterprise," ... of Dimes. "This new transdisciplinary, team-based research model will ...

Breaking Medicine News(10 mins):Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2 Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2 Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3 Health News:NYU's Movshon receives Lashley Award for his research on the neuroscience of vision 2 Health News:Hammerhead Bicycles Now a Standalone Brand 2 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3

[0] Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO [0] Depression May Raise Low Blood Sugar Risk in Diabetics [0] NYU's Movshon receives Lashley Award for his research on the neuroscience of vision [0] Hammerhead Bicycles Now a Standalone Brand [0] New multi-million dollar research center aims to solve the mystery of premature birth

... Tanaka, president and CEO of Menicon Co., Ltd. ... was appointed as Singapore,s Honorary Consul-General in Nagoya, ... Singapore. The appointment was effective April 20, 2009. ... corporate headquarters in Nagoya.(Photo: http://www.newscom.com/cgi-bin/prnh/20090508/PR34572 ...

... OAK BROOK, Ill., May 7 The University HealthSystem ... 3-year agreement to one supplier, Sodexo Inc., based in ... which has 2 optional 1-year renewal periods, became effective ... of comprehensive management solutions for food and nutrition services ...

... Congress to Make Health Reform Work for ChildrenSTANFORD, Calif., ... Stanford is joining the National Association of Children,s ... grassroots mobilization campaign asking Congress and the Obama Administration ... "Our hospital is extraordinarily proud to be taking ...

... 7 MedQuist Inc., (Nasdaq: MEDQ ) a ... technology-enabled clinical documentation workflow, today announced its unaudited operating results ... the first quarter of 2009 was $6.9 million, an increase ... a loss of $4.4 million was reported. Earnings per share ...

... 7 Trey Anastasio, lead singer of the rock band ... Wednesday, May 6, to participate in a day-long celebration marking ... National Association of Drug Court Professionals (NADCP) in calling for ... Mr. Anastasio recognized over fifteen members of Congress for their ...

... statement from Georges C. Benjamin, MD, FACP, FACEP (E), ... Public Health Association (APHA) joins other leading health organizations ... Obama,s FY 2010 budget."Of particular note is the $635 ... to finance health reform and ensure that we all ...

Dr. Tanaka Appointed as Honorary Consul-General by Republic of Singapore University HealthSystem Consortium Selects Sodexo to Provide Food and Nutrition Services Lucile Packard Children's Hospital at Stanford to Raise Its Voice for Kids in Health Care Reform Debate MedQuist Reports First Quarter 2009 Results Phish Frontman Trey Anastasio Visits Capitol Hill to Support Drug Courts and Calls on Congress to Put a Drug Court Within Reach of Every American in Need APHA Applauds Health Reform Fund and Other Health Investments in Budget

Reusable Components Compatible with VERSASTEP™ Reposable Access System....

The VersaStep™ 5 mm and VersaStep™ PLUS Reposable system components for creating each access port are supplied in separate packages....

... VERSASTEP™ Plus Long Instrument for ... ,The VERSASTEP™ Plus Long Instrument ... a unique endoscopic entry device ... procedures. It is used to ...

... Step™ and Mini Step™ device components are supplied ... Single Use System is supplied sterile in 2/3, ... in various configurations and combinations. They are used ... needle and the Step™ radially Expandable Sleeve. The ...

Medicine Products:

Reusable Components VersaStep™ Reposable Powershield™ (Reusable Radiolucent Cannulae - Short Length)VersaStep™ Plus Long Instrument with 150 mm Working Length STEP™ Short Instruments